Status:
UNKNOWN
To Compare Intravenous and Oral Hydration of the Prevention for CIN in Elderly Patients Undergoing Intravenous CECT
Lead Sponsor:
Yu Danqing
Conditions:
CIN
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography.
Detailed Description
The prospective multicenter randomized controlled clinical research discusses the comparison of oral and intravenous hydration for prevention of contrast-induced nephropathy in elderly patients with e...
Eligibility Criteria
Inclusion
- Age\>21
- informed consent
- Undergoing Intravenous Contrast-enhanced Computed Tomography
Exclusion
- CT enhancement was not performed;
- Dialysis treatment of patients with end-stage renal failure or heart, kidney transplantation;
- Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of examination;
- Acute decompensated heart failure;
- Allergic to radioactive contrast agent;
- Be subjected to life - threatening trauma;
- Severe infection;
- Surgery was performed within 2 days of CT examination.
- Combined with multiple myeloma, urinary obstruction, aortic dissection
- Can cause acute kidney injury disease;
- Use of aminoglycosides and other nephrotoxic drugs 2 weeks before.
Key Trial Info
Start Date :
October 8 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
1368 Patients enrolled
Trial Details
Trial ID
NCT03872739
Start Date
October 8 2016
End Date
October 1 2021
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong provincial people's hospital
Guanzhou, Guangdong, China, 510000